The relationship between treatment intensity and characteristics of patients with early-stage breast cancer. Differences in treatment intensity were observed for patients with differing demographic characteristics. Further...
Read More
Overall survival and progression-free survival enhanced with 177Lu-PSMA-617 A novel agent that...
Read More
Patients receiving chemotherapy for breast cancer do not have an increased risk for severe acute...
Read MoreThe ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...
Read MoreThe ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...
Read MoreThe ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...
Read More
TUESDAY, June 1, 2021 (HealthDay News) – Oncologists may substantially underestimate how many...
Read MoreAlthough assessing and reducing the severity of tardive dyskinesia (TD)—a persistent and potentially disabling movement disorder linked with exposure to antipsychotics and other dopamine receptor blocking agents—is crucial for...
Read More
New research was virtually presented at AACR 2021, the American Association for Cancer Research...
Read MoreBy: Cecilia Peterson; Amanda Glazar; Chirag Shah; Prakash Masand; Michael Lemon Introduction: Tardive Dyskinesia (TD) refers to abnormal, involuntary, choreoathetoid movements of the tongue, lips, face, trunk, and extremities...
Read MorePlasma neurofilament light chain (NfL) demonstrated to be a more valuable biomarker for neurodegeneration than total tau (T-tau) protein. This was the conclusion of the Mayo Clinic Study of Aging (MCSA), comparing the 2...
Read MoreNo association was found between the use of antidepressants (AD) and the occurrence of intracerebral hemorrhage (ICH) in a large population-based study of the Florida Stroke Registry (FSR), a voluntary stroke registry of Florida...
Read MoreObstructive sleep apnea (OSA) is prevalent among cognitively impaired patients and linked to reduced sleep quality and lowered cognitive capacities. David Colelli (University of Toronto, Canada) presented the results of his...
Read MoreIn patients who experienced a first clinical demyelinating event, baseline levels of serum neurofilament light chain (sNfL), a biomarker of neural damage, were associated with conversion to McDonald 2005 multiple sclerosis (MS)....
Read MorePreliminary results of a genome-wide-association study (GWAS) show a possible involvement of mast cells and neutrophils in the disease activity of relapsing-remitting MS patients [1]. These results provide important knowledge on...
Read MoreA 3-year prospective observational study investigating ATP changes in MS via T7 MRSI, comparing patients with and without vascular disease risk factors (VDRF), demonstrated that VDRF-positive patients had lower brain ATP rates...
Read MoreMS patients treated with anti-CD20 therapies ocrelizumab and rituximab have an increased risk of severe COVID-19 infection, whereas treatment with interferon or teriflunomide could reduce that risk. These were the preliminary...
Read MorePatients with advanced non-small cell lung cancer (NSCLC) experience fatigue and physical deconditioning, altering their quality of life (QoL). However, the safety and feasibility of high intensity exercise in advanced NSCLC has...
Read MoreThe ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...
Read MoreThe ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...
Read More
